Clinical Trial Update: Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating suprachoroidal triamcinolone acetonide with IVT aflibercept for macular edema after retinal vein occlusion has completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema
• Retinal Vein Occlusion

Drugs mentioned

• Aflibercept (Aflibercept)
• TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE)

Snippet

Sponsor: Clearside Biomedical, Inc. | Conditions: Macular Edema, Retinal Vein Occlusion | Phase 2 | Status: COMPLETED | Results posted: 2021-02-08